ArticlePain2020

Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier.

Agustin Melo-Carrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.